Trending Now
ARCA Biopharma Inc. (NASDAQ:ABIO) Submits IND Application For AB201 In Treating...
ARCA Biopharma Inc. (NASDAQ:ABIO) has announced the submission of an Investigational New Drug Application to the FDA to evaluate AB201 in treating hospitalized COVID-19...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Immunomedics Inc. (NASDAQ:IMMU) Reports Positive Phase 3 Trodelvy Study Results In...
Immunomedics Inc. (NASDAQ:IMMU) confirmatory third phase ASCENT study of Trodelvy met both the primary progression-free survival endpoint and the secondary endpoints in the previously...
MAKE IT MODERN
LATEST REVIEWS
Grindr Inc (NYSE:GRND) technical setup looks bullish post merger
Grindr Inc (NYSE:GRND) surged last Friday after the LGBTQ social networking platform's merger with special purpose acquisition company (SPAC) Tiga Acquisition Corp....
MAKE IT MODERN
PERFORMANCE TRAINING
Is Loyalty Ventures Inc (LYLT) more than a dead cat bounce
Shares of Loyalty Ventures Inc. (NASDAQ:LYLT) last traded at $0.2709, a gain of over +0.1009$ (+59.35%). More than 194,654,676 shares exchanged hands...
Blueprint Medicines Corp (NASDAQ: BPMC) is Developing Target Protein Degrader Medicines
Blueprint Medicines Corp (NASDAQ: BPMC) is collaborating with Proteovant Therapeutics to develop protein degrader medicines. Therapies that target protein degradation use the body's system...
Results from PRO2TECT Global Phase 3 Program of Vadadustat Were Top-Line; Akebia Therapeutics Inc...
Akebia Therapeutics Inc (NASDAQ:AKBA) has put in a lot of tenacity and innovation in developing novel therapeutics for people living with kidney disease. Over...
Long Term Growth Shopping Lists Should include Apparel Stocks with Big Stories (NKE, FBCD,...
The bear is growling angry right now on Wall Street, but that’s when savvy investors should be busy making shopping lists to...
Catalyst Pharmaceutical Inc.’s (NASDAQ: CPRX) Japanese Partner DyDo Pharma Commences Registrational Study of FIRDAPSE
Catalyst Pharmaceutical Inc. (NASDAQ: CPRX) has announced that its partner DyDo Pharma has commenced third phase registrational stud in Japan evaluating the safety and...
MAKE IT MODERN
